Support the news

Biogen Outgoing CEO Says Co. To Shutdown Its Oldest, Smallest Drug Manufacturing Site In Cambridge06:16
Download

Play
Biogen headquarters on Binney Street in Cambridge. (Jesse Costa/WBUR)
Biogen headquarters on Binney Street in Cambridge. (Jesse Costa/WBUR)
This article is more than 2 years old.

Big changes face Biogen, the largest biotech company in Massachusetts. The Cambridge-based company employing nearly 3,000 people in Mass. makes drugs for multiple sclerosis and is developing a drug for Alzheimer's.

But, it's shutting down its drug manufacturing in Massachusetts and laying off workers. It's also losing its top executive. CEO George Scangos, who is stepping down after six years on the job, joined Morning Edition.

This segment aired on December 19, 2016.

Deborah Becker Twitter Host/Reporter
Deborah Becker is a senior correspondent and host at WBUR. Her reporting focuses on mental health, criminal justice and education.

More…

+Join the discussion
TwitterfacebookEmail

Support the news